agilon health, inc.
NYSEAGL arrives at its August 5 earnings report having lost 6.5% over the past week and 14.5% over the past month — but options traders are still leaning heavily into the upside story, even as the analyst community remains sharply divided. The clearest read on near-term sentiment is in the options market. The put/call ratio fell further to 0.15 on July 31, now running more than three…
AGL cost to borrow jumps 136% in one week to 0.898%, driven by tightening short supply amid rising short interest.
AGL arrives at its August 5 earnings report having lost 6.5% over the past week and 14.5% over the past month — but options traders are still leaning heavily into the upside story, even as the analyst community remains…
Options traders are piling into calls on AGL ahead of next week's results. The put-call ratio hit 0.17 on July 30 — down 27% from its 20-day mean of 0.23. That reading sits more than three standard deviations below the…
Snapshot as of 7 Aug 2026
AGL is in the middle of one of the most dramatic reratings in health care this year — and the Street is scrambling to keep up. The stock gained 27% this week alone, hitting $88.20 as of Tuesday's close. The one-month…
AGL heads into the post-earnings session having tripled from the canvas — and the Street's response is already turning cooler. The stock closed Tuesday at $26.74, up 149% over the past month. That recovery traces…
AGL enters its Q1 2026 earnings release tomorrow with the sharpest analyst signal of the pre-print period arriving just hours ago: JP Morgan's Lisa Gill downgraded the stock to Underweight with a $21 target — a direct…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AGL — free to start on ORTEX.
Sign up for free →Open AGL on ORTEX